Cormorant Asset Management »

Compass Therapeutics shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.0M 2.0M 1.00
2024-03-31 $11M 5.6M 1.98

More positions owned by Cormorant Asset Management

Moonlake Immunotherapeutics Class A Ord (MLTX)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Arcellx Common Stock (ACLX)
Vaxcyte (PCVX)
Longboard Pharmaceuticals In (LBPH)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics (RAPP)
Crinetics Pharmaceuticals In (CRNX)
Edgewise Therapeutics (EWTX)
Merus N V (MRUS)
Bridgebio Pharma (BBIO)
Insmed Com Par $.01 (INSM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Janux Therapeutics (JANX)
Axsome Therapeutics (AXSM)

View all positions for Cormorant Asset Management

Top funds holding Compass Therapeutics

OrbiMed Advisors
Blackstone Group
BlackRock
BlackRock
Rock Springs Capital Management
Henderson Group
MPM Oncology Impact Management
Vanguard Group
Blue Owl Capital Holdings
Geode Capital Management
Cormorant Asset Management
State Street Corporation
Tang Capital Management
Baker Bros. Advisors
Northern Trust

View all funds holding Compass Therapeutics